Common genetic variants of the cardiac sodium channel alter patient response to class 1b antiarrhythmics
Authors:
Open Access
- 19 March 2026
- journal article
- Published by Elsevier in The Journal of Precision Medicine: Health and Disease
- Vol. 6
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Heart, Lung, and Blood Institute (R01 HL148803)
- American Heart Association (24PRE1198562)
- American Heart Association (960621)
This publication has 66 references indexed in Scilit:
- Characterizing fenestration size in sodium channel subtypes and their accessibility to inhibitorsBiophysical Journal, 2022
- Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statementAmerican Journal of Preventive Cardiology, 2021
- High-Throughput Reclassification of SCN5A VariantsThe American Journal of Human Genetics, 2020
- Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysisAnalytical Biochemistry, 2016
- Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anestheticsNaunyn-Schmiedeberg's Archives of Pharmacology, 2016
- Cardiac Na Channels2016
- Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implicationsHeart Failure Reviews, 2015
- Mexiletine: Pharmacology and therapeutic useClinical Cardiology, 1990
- Comparison of intravenous mexiletine and lidocaine for the treatment of ventricular arrhythmiasAmerican Heart Journal, 1986
- Oral mexiletine in the treatment of refractory ventricular arrhythmias: The role of electrophysiologic techniquesAmerican Heart Journal, 1984